China SXT Pharmaceuticals vs 60 Degrees Pharmaceuticals
China SXT Pharmaceuticals and 60 Degrees Pharmaceuticals are similar in size: $1.1m and $1.0m of revenue in their latest fiscal years. 60 Degrees Pharmaceuticals grew faster (65.5% against -34.6%). China SXT Pharmaceuticals kept more of each dollar of sales as profit: a net margin of -545.2% against -732.5%.
| Latest fiscal year | China SXT PharmaceuticalsSXTC, 2026 | 60 Degrees PharmaceuticalsSXTP, 2025 |
|---|---|---|
| Revenue | $1.1m | $1.0m |
| Revenue growth | -34.6% | 65.5% |
| Net income | −$6.2m | −$7.4m |
| Operating margin | -625.9% | — |
| Net margin | -545.2% | -732.5% |
| Return on equity | -27.5% | -196.4% |
| Free cash flow | −$4.0m | −$7.0m |
| Cash | $28.2m | $1.5m |
| Total debt | $999,565 | $152,775 |
| Debt to equity | 3.4% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $2.0m | $2.6m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 4 buys, 0 sales |